NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Zymergen

Zymergen

Public
Emeryville, CaliforniaBiotechwww.zymergen.com

Zymergen is now publicly traded

The data on this page reflects Zymergen's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Went Public

Apr 26, 2021

Last Round

Bankruptcy

Oct 3, 2023

Total Funding Raised

$1.76B

Company Overview

Zymergen is a biotechnology and materials science company that creates innovative microbe-based inputs and technologies for agricultural and industrial applications.

Sector

Biotech

AI Layer

Infrastructure

Keywords

automated synthetic biology platformmicrobe engineering for molecule manufacturingML-guided microbe engineeringsynthetic biology R&D servicesbio-manufactured materialsbio-manufactured polyimide filmdrug discovery from natural productsrobotic automation for biological R&Dhigh-throughput screening platformbio-based products for electronicsbio-based crop protection solutions

Zymergen Comparables

Compare Zymergen with similar companies based on industry and business-model similarity.

Zymergen comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Zymergen Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
BankruptcyOct 3, 2023
M&AOct 19, 2022
IPOApr 26, 2021
Series DSep 8, 2020
Series CDec 13, 2018
Series B
Oct 11, 2016

Zymergen Investors

Notable investors and investment history

Zymergen investors
InvestorRounds
Andreessen HorowitzSeries B
SoftBank Investment AdvisersSeries D, Series C
Threshold VenturesSeries A
ICONIQ CapitalSeries B
Perceptive AdvisorsSeries D
Union Square VenturesSeries A
Innovation EndeavorsSeries B, Series C, Series A

Zymergen Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Zymergen Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersEmeryville, California
Year Founded2013
Last FundingOct 3, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.